Cramer's Take on Headline Stocks
Stockpickr Staff
06/29/09 - 05:20 PM EDT
(Updated with stock prices.)Bernard Madoff, perpetrator of the multibillion-dollar Ponzi scheme that destroyed the financial health of hundreds, even thousands, of people, received a
150-year jail sentence on Monday morning.
Also making headlines,
Microsoft(MSFT Quote) might unload a 2007 acquisition, Razorfish, to a French marketing company. Microsoft closed up 51 cents, or $2.18, at $23.86 on Monday.
Swiss drug company
Novartis(NVS Quote) is reportedly considering a purchase of
Elan's(ELN Quote) multiple sclerosis treatment, Tsyabri, and other operations from the Irish biotech. Novartis closed down 17 cents at $41.17 on Monday, while Elan slid 41 cents, or 5.6%, to $6.95
And in
analyst upgrade-downgrade news, Deutsche Bank downgraded
Biogen Idec(BIIB Quote) to hold from buy, Friedman Billings Ramsey downgraded
Alcoa(AA Quote) to underperform, and Credit Suisse upgraded
KB Home(KBH Quote) to neutral from underperform.
Biogen lost $2.75, or 5.5%, on Monday to close at $47.32; Alcoa slid 32 cents, or 3%, to $10.44; and KB Home added 69 cents, or 5.1%, to $14.11.
With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.
To read more,
visit Stockpickr.com.